Schizophrenia is a neurodevelopmental disorder with genetic and environmental factors involved in its aetiology. Genetic liability contributing to the development of schizophrenia is a subject of extensive research activity, as reliable data regarding its aetiology would enable the improvement of its therapy and the development of new methods of treatment. A multitude of studies in this field focus on genetic variants, such as copy number variations (CNVs) or single-nucleotide variants (SNVs). Certain genetic disorders caused by CNVs including 22q11.2 microdeletion syndrome, Burnside-Butler syndrome (15q11.2 BP1-BP2 microdeletion) or 1q21.1 microduplication/microdeletion syndrome are associated with a higher risk of developing schizophrenia. In this article, we provide a unifying framework linking these CNVs and their associated genetic disorders with schizophrenia and its various neural and behavioural abnormalities.
CITATION STYLE
Szecówka, K., Misiak, B., Łaczmańska, I., Frydecka, D., & Moustafa, A. A. (2023, April 1). Copy Number Variations and Schizophrenia. Molecular Neurobiology. Springer. https://doi.org/10.1007/s12035-022-03185-8
Mendeley helps you to discover research relevant for your work.